EU Approval of AAV5 DetectCDx(TM) Provides Access to Companion Diagnostic for Hemophilia A Gene Therapy
SALT LAKE CITY, Nov. 10, 2023 -- (Healthcare Sales & Marketing Network) -- ARUP Laboratories today announced that it has gained the Conformité Européenne (CE) mark for AAV5 DetectCDx single-site use under the European Union's In Vitro Diagn... Diagnostics, Regulatory ARUP Laboratories, BioMarin Pharmaceutical, AAV5 DetectCDx, hemophilia A
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Gene Therapy | Genetics | Haemophilia | Hemophilia | Marketing | Pharmaceuticals | Sodium Chloride